Press Release | ImmuneMed

Press Release

Home
Company News
Publicity
COVID-19 Phase 2 Clinical Study Approval (Indonesia), December 1st, 2020
Writer|
Views |
Date|


 

Prev 및 Next
Prev Obtaining Approval Letter of Investigational New Drug (IND) for COVID-19 Phase 2
Study in Republic of Korea on 7th December, 2020
2020-12-07
Next COVID-19 Phase 2 Clinical Study Approval (Russia), October 15th, 2020
2020-11-10